Skip to content

Imanib

Generic Name
Imatinib Mesylate
Therapeutic Area
Hematology
Therapeutic Class
Antineoplastic – BCR-ABL Tyrosine Kinase Inhibitor
Dosage Form
Tablets
Strength
100 mg & 400 mg
Pack Size
30's & 60’s
Registration Number
130715 & 130716

Overview

Imatinib is a small molecule kinase inhibitor used to treat certain types of cancer. It is used in treating chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs) and a number of other malignancies.

Indication

Imatinib is a targeted tyrosine kinase inhibitor primarily used to treat various blood cancers and specific solid tumors. Its core indication revolves around cancers driven by abnormal cell growth proteins, most notably the Philadelphia chromosome-positive (Ph+) mutation.